These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3608626)

  • 1. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
    Weidekamm E; Schwartz DE; Dubach UC; Weber B
    Chemotherapy; 1987; 33(4):259-65. PubMed ID: 3608626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
    Schwartz DE; Weidekamm E; Mimica I; Heizmann P; Portmann R
    Chemotherapy; 1987; 33(1):1-8. PubMed ID: 3493885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.
    Karbwang J; Bunnag D; Breckenridge AM; Back DJ
    Eur J Clin Pharmacol; 1987; 32(2):173-7. PubMed ID: 3495440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
    Mansor SM; Navaratnam V; Mohamad M; Hussein S; Kumar A; Jamaludin A; Wernsdorfer WH
    Br J Clin Pharmacol; 1989 Mar; 27(3):381-6. PubMed ID: 2785812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
    Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet.
    Wang NS; Guo XB; Liu QD; Fu LC; Li GQ; Arnold K
    Chemotherapy; 1990; 36(3):177-84. PubMed ID: 2338028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic aspects of a pyrimethamine combination with sulfanilamides].
    Lur'e AA; Shcherbakov AM; Lue TV; Nguyen TN; Le DD
    Med Parazitol (Mosk); 1986; (4):10-5. PubMed ID: 3531793
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
    Timm U; Weidekamm E
    J Chromatogr; 1982 Jun; 230(1):107-14. PubMed ID: 6980889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man.
    Edstein MD
    Chemotherapy; 1987; 33(4):229-33. PubMed ID: 3608621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
    Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
    Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
    Tin F; Hlaing N; Tun T; Win S; Lasserre R
    Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications.
    Salako LA
    Ann Ist Super Sanita; 1985; 21(3):315-25. PubMed ID: 3914849
    [No Abstract]   [Full Text] [Related]  

  • 17. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of mefloquine.
    Karbwang J; White NJ
    Clin Pharmacokinet; 1990 Oct; 19(4):264-79. PubMed ID: 2208897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP; Tangri AN; Nityanand S
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
    Eamsila C; Singharaj P; Yooyen P; Chatnugrob P; Nopavong Na Ayuthya A; Webster HK; Lasserre R; Mittelholzer ML; Stürchler D
    Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):672-6. PubMed ID: 7939938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.